Búsqueda avanzada
Instrumentos
Nombre | Mnemo | Bolsa de valores | Volumen promedio | Cotización | Tipo | |
---|---|---|---|---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Japan Exchange +8 Otros | 3 534 493 | 4.202 JPY | Acción | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Deutsche Boerse AG | - | 24,43 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 0RN3 | London S.E. | 0 | 37,59 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Börse Stuttgart | - | 24,39 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | BOERSE MUENCHEN | 104 | 24,6 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKPHF | OTC Markets | 2 037 | 26,86 USD | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Wiener Boerse | - | 24,78 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Fukuoka Stock Exchange | 0 | 4.080 JPY | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Sapporo S.E. | 0 | 4.300 JPY | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAKP34 | Sao Paulo | 413 | 69,86 BRL | Acción | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAK | Nyse +5 Otros | 1 258 872 | 13,36 USD | Acción | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAK N | Mexican S.E. | 4 851 | 240,5 MXN | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | Deutsche Boerse AG | - | 12,1 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | Börse Stuttgart | - | 12,2 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | BOERSE MUENCHEN | - | 12,3 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 0A87 | London S.E. | 848 | 13,07 USD | ||
TAKEDA IP HOLDINGS CO.,LTD. | 7875 | Japan Exchange | 8 007 | 859 JPY | Acción | |
TAKEDA MACHINERY CO., LTD. | 6150 | Japan Exchange | 6 913 | 3.345 JPY | Acción | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Deutsche Boerse AG | - | 95,4 % | Obligacion | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAK29 | Nyse | - | - % | Obligacion | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAK40A | Nyse | - | - % | Obligacion | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | BOERSE MUENCHEN | - | 91,72 % | Obligacion | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | BOERSE MUENCHEN | - | 83,79 % | Obligacion |
Empresas (6)
Takeda Pharmaceutical Company Limited está especializada en el desarrollo, la fabricación y la comercialización de productos farmacéuticos especialmente para enfermedades metabólicas y cardiovasculares, cánceres y problemas del sistema nervioso central. L ...
Takeda iP Holdings Co Ltd, anteriormente Takeda Printing Co Ltd, se dedica principalmente al negocio de la impresión. La empresa opera en dos segmentos empresariales. El segmento de impresión tiene dos negocios. El negocio de impresión se dedica a la plan ...
Affymax, Inc. es una empresa biofarmacéutica. El producto OMONTYS (peginesatida) de la empresa está destinado al tratamiento de la anemia debida a la enfermedad renal crónica en pacientes adultos en diálisis. OMONTYS es un agente estimulante de la eritrop ...
TAKEDA MACHINERY CO., LTD. es una empresa con sede en Japón que se dedica principalmente a la fabricación y venta de máquinas de procesamiento de acero conformado y máquinas de sierra circular para el procesamiento de marcos de acero, materiales de acero, ...
Ligand Pharmaceuticals Incorporated es una empresa biofarmacéutica que permite el avance científico mediante el apoyo al desarrollo clínico de medicamentos. La empresa lo hace proporcionando financiación, concediendo licencias de sus tecnologías o ambas c ...
DRI Healthcare Trust es una empresa con sede en Canadá que se dedica a proporcionar financiación para impulsar la innovación en la industria de las ciencias de la vida. La empresa se dedica a la monetización de royalties farmacéuticos y proporciona capita ...
Insiders
El Sr. Norimasa Takeda es Director de Contabilidad y Controlador Corporativo de Takeda Pharmaceutical Co.
En la actualidad, Norimasa Kitazawa es presidente y director representante de Pigeon Corp.
En la actualidad, Norimasa Sato ocupa el cargo de Director Financiero y Director General Senior en Welcia Holdings Co., Ltd. y Auditor de Welcia Kaigo Service Co., Ltd. El Sr. Sato también forma parte del consejo de administración de Welcia Yakkyoku Co. En su anterior carrera profesional, ocupó el cargo de auditor corporativo en Ouen Kazoku Co.
En la actualidad, Chikashi Takeda ocupa el puesto de Director Financiero en Olympus Corp. En el pasado ocupó el cargo de Director Ejecutivo y Jefe de Finanzas en Astellas Pharma, Inc.
En la actualidad, Kazunori Takeda ocupa el cargo de Vicepresidente Ejecutivo y Presidente de Comercio de Rakuten, Inc. El Sr. Takeda también forma parte del consejo de administración de Gurunavi, Inc., Rakuten General Insurance Co., Ltd., Fusion Communications Corp. y Rakuten Vissel Kobe, Inc. Obtuvo un MBA en la Harvard Business School.
Kazuhiko Takeda forma parte del consejo de administración de Sony (China) Co., Ltd. y es director ejecutivo de Sony Corp.
Norimasa Maida formerly worked at Toyo Seikan Group Holdings Ltd., as Director & Managing Executive Officer from 2015 to 2016 and Toyo Kohan Co., Ltd., as Executive Officer & GM-Chemical Products Planning from 2011 to 2016.
Norimasa Shinya is currently working as a Senior Analyst at Mizuho Securities Co., Ltd.
(Broker).
Norimasa Tamura has a current job as a Non-Executive Director at The Chugoku Electric Power Co., Inc.
Norimasa Matsuoka formerly worked at TTCL Public Co. Ltd., as Director and Chiyoda Corp., as Manager-Petroleum & Petrochemicals Group from 2000 to 2015.
Mr. Matsuoka received his graduate degree from Keio University.
Norimasa Kunimoto currently works at Terumo Europe NV (Belgium), as Chief Executive Officer from 2018, Terumo France SAS, as Chairman, Terumo (Deutschland) GmbH, as Co-Managing Director, and Terumo UK Ltd., as Director.
Norimasa Yamamizu is currently working as the Director, Executive Officer & GM-Foodstuffs at Shinyei Kaisha.
Norimasa Tanabe is currently a Partner at Ant Capital Partners Co., Ltd.
since 2009.
He previously worked as a Director at Kagayaku Cosmetics, Inc.
Norimasa Goto is currently holding multiple positions as Vice Chairman at NIDEC (Dalian) Ltd., Nidec (Dongguan) Corp., and Nidec Vietnam Corp.
He is also currently serving as Chairman at Nidec (Hong Kong) Co., Ltd.
In the past, he worked as a Director at NIDEC Corp.
Norimasa Iida currently works at ONO SOKKI Co., Ltd., as Independent Outside Director from 2019.
Mr. Norimasa Ogawa is a Research Analyst at Daiwa Securities Capital Markets Co. Ltd.
Norimasa Komatsu is currently the President & Representative Director at Genesis Technology, Inc. since 1997.
Prior to this, he worked at Kobe Steel, Ltd.
as a Principal from 1974 to 1998.
Norimasa Takeshima held the position of President & Representative Director at Daido Sittipol Co. Ltd.
and Executive Officer at Daido Kogyo Co., Ltd.
Norimasa Okubo currently works as an Executive Officer at Kokubu Group Corp.
Norimasa Higashi is currently a Director at Daido General Service KK.
Previously, he worked as an Executive Officer & General Manager-Procurement at Daido Kogyo Co., Ltd.
Norimasa Yoshida is an Independent Outside Director at Benefit Japan Co., Ltd.
since 2016.
He previously held positions as Chairman at Senshu Ikeda Holdings, Inc. and The Senshu Ikeda Bank Ltd., and as President at Senshu Bank Ltd.
Norimasa Somiya held positions as a Director at Osaka Steel Co., Ltd., an Independent Director at Chubu Steel Plate Co., Ltd., and a Manager at Nagoya Steel Plant for Nippon Steel Corp.
Norimasa Sakata has worked as an Auditor at Mitani Sangyo Co., Ltd.
since 2016.
Norimasa Kurata currently works at Union Tool Co., as Executive Officer & General Manager-Administration.
Toru Takeda is currently working as an Auditor at Seikagaku Corp.
He started this position in 2016.
Previously, he worked as an Auditor at Mizuho Trust & Banking Co., Ltd.
Yasuhumi Takeda is associated with Milbon Co., Ltd.
since 1981.
He currently holds the position of Director & General Manager-Development, which he started in 2014.
Tsuneharu Takeda is an Outside Director at Mandarin Oriental Tokyo Co., Ltd.
since 2013.
He previously served as an Independent Outside Director at Kureha Corp.
and as an Outside Director at KCJ Group, Inc.
Keiji Takeda currently works at IRISO Electronics Co., Ltd., as Director, EVP & General Manager-Manufacturing from 2023.
Yoshisada Takeda worked as the Director and Head of Sales & Real Estate at Takenaka Corp..
Mr. Takeda attended Keio University where he received his undergraduate degree in 1972.
Hideki Takeda is the founder of Scent Science International, Inc. He is currently an Independent Outside Director at Modalis Therapeutics Corp., a Representative Director at Medical Patent Research, Inc., an Outside Director at Ctex Co. Ltd., and a Director at Liid Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from Osaka University.
Yutaka Takeda has worked as an Auditor at Onamba Co., Ltd.
since 2014.
Toru Takeda currently works at TV Asahi Corp.
(New), as Vice Chairman from 2019 and TV Asahi Holdings Corp., as Director from 2019.
No hay resultados para esta búsqueda
- Bolsa de valores
- Búsqueda avanzada
- Norimasa Takeda